Designs for Group Sequential Phase II Clinical Trials

DOI10.2307/2531540zbMath0715.62244OpenAlexW2316588149WikidataQ52583941 ScholiaQ52583941MaRDI QIDQ3201547

Terry M. Therneau, Stephan S. Cha, Myron N. Chang, Harry S. Wieand

Publication date: 1987

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2531540

zbMATH Keywords

clinical trialsoptimal design

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)

Related Items (12)

Assurance test and its equivalent truncated sequential test ⋮ Nearly optimal truncated group sequential test on binomial proportions ⋮ Methodology and application of adaptive and sequential approaches in contemporary clinical trials ⋮ A class of confidence intervals for sequential phase II clinical trials with binary outcome ⋮ On the maximum total sample size of a group sequential test about binomial proportions. ⋮ On Bayesian estimators in multistage binomial designs ⋮ Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials ⋮ On the maximum total sample size of a group sequential test about bivariate binomial propor\-tions ⋮ Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity ⋮ Two-Stage Designs with Additional Futility Tests for Phase II Clinical Trials with Heterogeneous Patient Populations ⋮ A review of phase 2-3 clinical trial designs ⋮ MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION

This page was built for publication: Designs for Group Sequential Phase II Clinical Trials